Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 4 Jan 2008 |
| Articles of Association of Genmab A/S dated December 13, 2007 | 4 Jan 2008 |
| Genmab to Present at the 26th Annual JPMorgan Healthcare Conference | 3 Jan 2008 |
| R1507 Antibody to Enter Phase II Study to Treat Sarcoma | 20 Dec 2007 |
| Genmab Announces Update on Ofatumumab Program | 14 Dec 2007 |